Covered recipient · General Payments record
REBECCA L DANFORTH
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2019–2025
$2,207.76
- Reported across 142 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $462.29 | 29 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $200.68 | 15 |
| GlaxoSmithKline, LLC. | $106.38 | 6 |
| PFIZER INC. | $57.41 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $51.16 | 2 |
| Amgen Inc. | $46.66 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.58 | 01/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723081 | CMS |
| ABBVIE INC. | $7.03 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723083 | CMS |
| ABBVIE INC. | $7.88 | 02/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723085 | CMS |
| ABBVIE INC. | $5.57 | 03/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723087 | CMS |
| ABBVIE INC. | $9.04 | 03/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723089 | CMS |
| ABBVIE INC. | $29.94 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723091 | CMS |
| ABBVIE INC. | $7.56 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723093 | CMS |
| ABBVIE INC. | $8.76 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723095 | CMS |
| ABBVIE INC. | $9.90 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723097 | CMS |
| ABBVIE INC. | $5.84 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723099 | CMS |
| ABBVIE INC. | $3.89 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723101 | CMS |
| ABBVIE INC. | $2.94 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723103 | CMS |
| ABBVIE INC. | $26.31 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723105 | CMS |
| ABBVIE INC. | $29.67 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723107 | CMS |
| ABBVIE INC. | $22.77 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201723109 | CMS |
| Amgen Inc. | $17.36 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228506004 | CMS |
| Amgen Inc. | $15.81 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228506002 | CMS |
| Amgen Inc. | $13.49 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227079289 | CMS |
| GlaxoSmithKline, LLC. | $19.54 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190678751 | CMS |
| GlaxoSmithKline, LLC. | $17.88 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190701366 | CMS |
| GlaxoSmithKline, LLC. | $20.22 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190397544 | CMS |
| GlaxoSmithKline, LLC. | $16.76 | 07/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191530013 | CMS |
| GlaxoSmithKline, LLC. | $13.96 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191735571 | CMS |
| GlaxoSmithKline, LLC. | $18.02 | 10/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190811690 | CMS |
| Novartis Pharmaceuticals Corporation | $22.75 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200110091 | CMS |
| Novartis Pharmaceuticals Corporation | $28.41 | 07/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200110095 | CMS |
| PFIZER INC. | $14.69 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231496047 | CMS |
| PFIZER INC. | $20.30 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231328070 | CMS |
| PFIZER INC. | $22.42 | 07/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231701039 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.